快速细孔（微创）钻颅在重症高血压性脑出血中的应用研究
|
摘要
目的
研究快速细孔(微创)钻颅在重症高血压性脑出血中的临床应用,评价其临床价值。
方法
回顾性分析2002～2009年山东省千佛山医院神经外科收治且行外科治疗的236例重症高血压性脑出血(脑出血后意识状况分级Ⅳ-Ⅴ级,格拉斯哥昏迷评分GCS≤9分)患者的临床资料,并按照手术方式不同分为钻孔组和开颅组,钻孔组局麻下行快速细孔(微创)钻颅引流术,开颅组全麻下行开颅血肿清除术,其中钻孔组163例、开颅组73例；术前对组间可能影响疗效的相关因素如性别、年龄、高血压病史、血肿部位及血肿量、发病至手术的时间等进行统计学分析；术中对手术时间进行比较；术后1天、7天、14天、30天复查颅脑CT评价颅内情况,术后1个月评价格拉斯哥预后评分GOS以比较其近期疗效,并分析病死率及再出血、糖和电解质代谢紊乱、肺部感染、颅内感染等主要并发症的情况。
结果
1.手术时间比较：钻孔组(8.7±3.9)分钟明显少于开颅组(136.5±19.6)分钟。
2.术后并发症比较：①钻孔组术后肺部感染患者55例(33.7%)；开颅组35例(47.9%)；钻孔组低于开颅组。②钻孔组术后高血糖与水电解质代谢平衡紊乱49例(30.1%)；开颅组31例(42.5%)；钻孔组低于开颅组。③钻孔组术后颅内感染患者15例(9.2%)；开颅组6例(8.2%)；两组不具有显著性差异。④钻孔组术后再出血患者17例(10.4%)；开颅组8例(11%)；两组不具有显著性差异。
3.近期疗效比较：术后1月近期疗效两组样本血肿量较小的患者(基底节区≤60ml、脑叶≤60ml、小脑≤15ml),钻孔组优于开颅组。两组样本间中大血肿量的患者(基底节区60～90ml、基底节区≥90ml、脑叶60～90ml、脑叶≥90ml、小脑>15ml)钻孔组与开颅组不具有显著性差异。脑干出血的患者1例行血肿腔钻孔引流术,4例行侧脑室钻孔引流术,GOS3分的患者2例(40%)；2分的患者1例(20%)；1分的患者2例(40%)。
4.术后1月死亡患者(GOS=1分)比较：钻孔组死亡患者57例(35.0%)死因分析：术后再出血死亡14例,术后病情继续进展死亡21例,多脏器功能衰竭死亡22例；开颅组患者28例(38.4%),死因分析：术后再出血死亡6例,术后病情继续进展死亡11例,多脏器功能衰竭死亡11例。两组总体死亡率,不具有统计学差异；基底节区出血、脑叶出血、小脑出血不同出血量间比较都不具有统计学差异；脑干出血死亡2例(40%)。
结论
快速细孔(微创)钻颅所需器械简单、不需全麻、创伤小、操作快捷：①钻孔组手术时间明显少于开颅组；②钻孔组术后肺部感染及高血糖与水电解质代谢平衡紊乱的发生率低于开颅组；术后颅内感染及再出血的患者与开颅组无差异；③钻孔组基底节区、脑叶及小脑血肿量较小的患者的近期疗效优于开颅组,中大血肿量的患者与开颅组无差异；脑干出血的患者术后1月重残2例(40%)；植物生存1例(20%)；死亡2例(40%)；④钻孔组与开颅组总体死亡率及基底节区出血、脑叶出血、小脑出血不同出血量间比较均无差异。
Objeetive
Research swift pore (minimally invasive) drilling cranial nerve surgery in Severe Hypertensive Intracerebral Hemorrhage and evaluate its clinical value.
Methods
We analyzed retrospectively clinical data of 236 patients of Severe Hypertensive Intracerebral Hemorrhage (Awareness of the situation after cerebral hemorrhage grade IV-V class, GCS≤9 points) from 2002 to 2009 in Qianfoshan Hospital in Shandong Province. And follow the surgical procedure were divided into groups and craniotomy group drilling, drilling under local anesthesia group rapid pore (minimally invasive) drilling drainage surgery, craniotomy group anesthesia and hematoma evacuation, which groups 163 drilling cases, craniotomy group of 73 patients; before surgery the relevant factors that may affect the efficacy such as gender, age, history of hypertension, hematoma locationand hematoma volume and time from onset to surgery were statistically analyzed; operation time were compared; after 1 day,7 days,14 days,30 days, review head CT evaluation of intracranial cases, evaluation after 1 month Glasgow Outcome Scale GOS, and statistically compare mortality and rebleeding, sugar and electrolyte metabolism disorders, pulmonary infection, intracranial infection and other major complications.
Results
1. Operation time:drilling group (8.7±3.9) minutes, significantly less than the craniotomy group (136.5±19.6) minutes.
2. Comparison of postoperative complications:①drilling group were 55 cases of pulmonary infection (33.7%); craniotomy group of 35 patients (47.9%); drilling group than craniotomy group.②drilling group were high blood sugar metabolism of water and electrolyte balance disorders and 49 cases (30.1%); craniotomy in 31 cases (42.5%); drilling group than craniotomy group.③drilling group were 15 cases of intracranial infection (9.2%),; Craniotomy 6 patients (8.2%),; two groups was not significant difference.④drilling group were 17 patients with rebleeding (10.4%); craniotomy 8 patients (11%); the two groups was not significant difference.
3. Comparison of curative effect: 1 month after surgery, the recent efficacy between patients with relatively small hematoma(basal ganglia≤60ml, cerebral lobes≤60ml, cerebellum≤15ml), drilling was better than craniotomy groups. Large hematoma volume(basal ganglia 60-90ml, basal ganglia≥90ml, cerebral lobes 60-90ml, cerebral lobes≥90ml, cerebellum>15ml) in patients with cranial drilling group showed no significant group differences. Brainstem hemorrhage hematoma in patients with a routine cavity drainage hole,4 hole routine lateral drainage, GOS3 points in 2 cases (40%); 2 points 1 case patients (20%); 1 point 2 cases (40%).
4. the death of patients after 1 month (GOS= 1):Drilling group 57 patients died (35.0%), the cause of death analysis:14 cases died of postoperative bleeding, disease continues to progress after the death of 21 cases, multiple organ failure in 22 cases of death; craniotomy group of 28 patients (38.4%), the cause of death analysis:6 died of postoperative bleeding, disease continues to progress after the death of 11 cases, multiple organ failure and 11 died. Two overall mortality was not statistically different; basal ganglia hemorrhage, lobar hemorrhage, cerebellar hemorrhage compared with different amount of bleeding is not statistically different between; brain stem hemorrhage and 2 cases died (40%).
Conclusion
Swift pore (minimally invasive) drilling skull craniotomy drainage method and compared to the required simple equipment, without anesthesia, trauma, operating fast:①drilling operation time was less than craniotomy group;②drilling postoperative pulmonary infection and high blood sugar and water electrolyte metabolism disorder in the incidence of lower cranial group; postoperative intracranial infection and re-bleeding was no difference between patients and craniotomy;③drilling group basal ganglia, cerebral lobes and cerebellar hematoma volume in patients with smaller Recent effective than craniotomy group, large hematoma volume was no difference between patients and craniotomy; brain stem hemorrhage in patients with severe disability after January 2 (40%); plants in 1 (20%); death 2 cases (40%);④drilling group and the craniotomy group overall mortality and basal ganglia hemorrhage, lobar hemorrhage, cerebellar hemorrhage was no different to compare differences in blood loss.
研究快速细孔(微创)钻颅在重症高血压性脑出血中的临床应用,评价其临床价值。
方法
回顾性分析2002～2009年山东省千佛山医院神经外科收治且行外科治疗的236例重症高血压性脑出血(脑出血后意识状况分级Ⅳ-Ⅴ级,格拉斯哥昏迷评分GCS≤9分)患者的临床资料,并按照手术方式不同分为钻孔组和开颅组,钻孔组局麻下行快速细孔(微创)钻颅引流术,开颅组全麻下行开颅血肿清除术,其中钻孔组163例、开颅组73例；术前对组间可能影响疗效的相关因素如性别、年龄、高血压病史、血肿部位及血肿量、发病至手术的时间等进行统计学分析；术中对手术时间进行比较；术后1天、7天、14天、30天复查颅脑CT评价颅内情况,术后1个月评价格拉斯哥预后评分GOS以比较其近期疗效,并分析病死率及再出血、糖和电解质代谢紊乱、肺部感染、颅内感染等主要并发症的情况。
结果
1.手术时间比较：钻孔组(8.7±3.9)分钟明显少于开颅组(136.5±19.6)分钟。
2.术后并发症比较：①钻孔组术后肺部感染患者55例(33.7%)；开颅组35例(47.9%)；钻孔组低于开颅组。②钻孔组术后高血糖与水电解质代谢平衡紊乱49例(30.1%)；开颅组31例(42.5%)；钻孔组低于开颅组。③钻孔组术后颅内感染患者15例(9.2%)；开颅组6例(8.2%)；两组不具有显著性差异。④钻孔组术后再出血患者17例(10.4%)；开颅组8例(11%)；两组不具有显著性差异。
3.近期疗效比较：术后1月近期疗效两组样本血肿量较小的患者(基底节区≤60ml、脑叶≤60ml、小脑≤15ml),钻孔组优于开颅组。两组样本间中大血肿量的患者(基底节区60～90ml、基底节区≥90ml、脑叶60～90ml、脑叶≥90ml、小脑>15ml)钻孔组与开颅组不具有显著性差异。脑干出血的患者1例行血肿腔钻孔引流术,4例行侧脑室钻孔引流术,GOS3分的患者2例(40%)；2分的患者1例(20%)；1分的患者2例(40%)。
4.术后1月死亡患者(GOS=1分)比较：钻孔组死亡患者57例(35.0%)死因分析：术后再出血死亡14例,术后病情继续进展死亡21例,多脏器功能衰竭死亡22例；开颅组患者28例(38.4%),死因分析：术后再出血死亡6例,术后病情继续进展死亡11例,多脏器功能衰竭死亡11例。两组总体死亡率,不具有统计学差异；基底节区出血、脑叶出血、小脑出血不同出血量间比较都不具有统计学差异；脑干出血死亡2例(40%)。
结论
快速细孔(微创)钻颅所需器械简单、不需全麻、创伤小、操作快捷：①钻孔组手术时间明显少于开颅组；②钻孔组术后肺部感染及高血糖与水电解质代谢平衡紊乱的发生率低于开颅组；术后颅内感染及再出血的患者与开颅组无差异；③钻孔组基底节区、脑叶及小脑血肿量较小的患者的近期疗效优于开颅组,中大血肿量的患者与开颅组无差异；脑干出血的患者术后1月重残2例(40%)；植物生存1例(20%)；死亡2例(40%)；④钻孔组与开颅组总体死亡率及基底节区出血、脑叶出血、小脑出血不同出血量间比较均无差异。
Objeetive
Research swift pore (minimally invasive) drilling cranial nerve surgery in Severe Hypertensive Intracerebral Hemorrhage and evaluate its clinical value.
Methods
We analyzed retrospectively clinical data of 236 patients of Severe Hypertensive Intracerebral Hemorrhage (Awareness of the situation after cerebral hemorrhage grade IV-V class, GCS≤9 points) from 2002 to 2009 in Qianfoshan Hospital in Shandong Province. And follow the surgical procedure were divided into groups and craniotomy group drilling, drilling under local anesthesia group rapid pore (minimally invasive) drilling drainage surgery, craniotomy group anesthesia and hematoma evacuation, which groups 163 drilling cases, craniotomy group of 73 patients; before surgery the relevant factors that may affect the efficacy such as gender, age, history of hypertension, hematoma locationand hematoma volume and time from onset to surgery were statistically analyzed; operation time were compared; after 1 day,7 days,14 days,30 days, review head CT evaluation of intracranial cases, evaluation after 1 month Glasgow Outcome Scale GOS, and statistically compare mortality and rebleeding, sugar and electrolyte metabolism disorders, pulmonary infection, intracranial infection and other major complications.
Results
1. Operation time:drilling group (8.7±3.9) minutes, significantly less than the craniotomy group (136.5±19.6) minutes.
2. Comparison of postoperative complications:①drilling group were 55 cases of pulmonary infection (33.7%); craniotomy group of 35 patients (47.9%); drilling group than craniotomy group.②drilling group were high blood sugar metabolism of water and electrolyte balance disorders and 49 cases (30.1%); craniotomy in 31 cases (42.5%); drilling group than craniotomy group.③drilling group were 15 cases of intracranial infection (9.2%),; Craniotomy 6 patients (8.2%),; two groups was not significant difference.④drilling group were 17 patients with rebleeding (10.4%); craniotomy 8 patients (11%); the two groups was not significant difference.
3. Comparison of curative effect: 1 month after surgery, the recent efficacy between patients with relatively small hematoma(basal ganglia≤60ml, cerebral lobes≤60ml, cerebellum≤15ml), drilling was better than craniotomy groups. Large hematoma volume(basal ganglia 60-90ml, basal ganglia≥90ml, cerebral lobes 60-90ml, cerebral lobes≥90ml, cerebellum>15ml) in patients with cranial drilling group showed no significant group differences. Brainstem hemorrhage hematoma in patients with a routine cavity drainage hole,4 hole routine lateral drainage, GOS3 points in 2 cases (40%); 2 points 1 case patients (20%); 1 point 2 cases (40%).
4. the death of patients after 1 month (GOS= 1):Drilling group 57 patients died (35.0%), the cause of death analysis:14 cases died of postoperative bleeding, disease continues to progress after the death of 21 cases, multiple organ failure in 22 cases of death; craniotomy group of 28 patients (38.4%), the cause of death analysis:6 died of postoperative bleeding, disease continues to progress after the death of 11 cases, multiple organ failure and 11 died. Two overall mortality was not statistically different; basal ganglia hemorrhage, lobar hemorrhage, cerebellar hemorrhage compared with different amount of bleeding is not statistically different between; brain stem hemorrhage and 2 cases died (40%).
Conclusion
Swift pore (minimally invasive) drilling skull craniotomy drainage method and compared to the required simple equipment, without anesthesia, trauma, operating fast:①drilling operation time was less than craniotomy group;②drilling postoperative pulmonary infection and high blood sugar and water electrolyte metabolism disorder in the incidence of lower cranial group; postoperative intracranial infection and re-bleeding was no difference between patients and craniotomy;③drilling group basal ganglia, cerebral lobes and cerebellar hematoma volume in patients with smaller Recent effective than craniotomy group, large hematoma volume was no difference between patients and craniotomy; brain stem hemorrhage in patients with severe disability after January 2 (40%); plants in 1 (20%); death 2 cases (40%);④drilling group and the craniotomy group overall mortality and basal ganglia hemorrhage, lobar hemorrhage, cerebellar hemorrhage was no different to compare differences in blood loss.
引文
1.王忠诚主编.《王忠诚神经外科学》[M].湖北科学技术出版社,武汉,2005.
2. Magladery JW. The natural course of cerebrovascular hemorrhage [J].Clin Neurosurg.1963;9:106-13.
3. Donley,John James Wepfer.A renaissance student of apoplexy[J].Bull Johns Hopkins Hosp.1909,20:1-2.
4. Clarke E.Cerebrovascular system-historical aspects [M]. Radiology of the Skull and Brain,1974:875-889.
5. Fazio C.Clinical pathology of hypertensive intracerebral hemorrhage:Historical aspects[M].Raven Press,1983:105-113.
6. MacEwen W.An address on the surgery of the brain and spinal cord[M].BMJ 1888,20:302-309.
7. Cushing H.The blood-pressure reaction of acute cerebral compression,illustrated by cases of intracranial hemorrhage [J]. Am J Med Sci 1903,125:1017-1044.
8. Broderick J, Connolly S, Feldmann E,et al.Guidelines for the management of spontaneous intracerebral hemorrhage in adults:2007 update:a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group [J]. Stroke.2007; 38(6):2001-23.
9. Bagley CJ.Spontaneous cerebral hemorrhage:Disscussion of four types,with surgical considerations [J]. Arch Neurol Psychiatry,1932,27:1133-1174.
10. Robinson G.Encapsulates brain hemorrhage:A study of their frequency and pathology[J]. Arch Neurol Psychiatry,1932,27:1441-1444.
11. Craig W,Adson A.Spontaneous intracerebral hemorrhage:Etiology and surgical treatment with a report of nine cases[J]. Arch Neurol Psychiatry,1936,35:701-714.
12. Penfild W.The operative treatment of Spontaneous intracerebral hemorrhage[J]. Can Med Assoc J,1933,28:369-379.
13. LAZORTHES G. Surgery of cerebral hemorrhage; report on the results of 52 surgically treated cases[J]. J Neurosurg.1959;16(4):355-364.
14. McKissock W. Primary intracerebral hemorrhage:A controlled trial of surgical and conservative treatmene in 180 unselected cases[J]. Lancet 1961,2:221-226.
15. Sun TK, Chiu SC, Yeh SH, Chang KC. Assessing reliability and validity of the Chinese version of the stroke scale:scale development [J]. Int J Nurs Stud.2006 May; 43(4):457-63.
16. Towfighi A,Greenberg SM,Rosand J.Treatment and prevention of primary intracerebral hemorrhage [J]. Semin Neurol,2005,25 (4):445-452.
17. Herman M,Dvorak P,Houdek M.CT-guided stereotaxy:First 10-year experience [J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2003,147(2):221-226.
18. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G.Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. [J].Stroke.1993 Jul;24(7):987-93.
19.戴秀珍.锥颅或钻颅血肿引流术治疗脑出血的适应症、手术时机及手术方式选择[J].临床神经病学杂志,2001,14(2)：112-114.
20. Siddique MS,Fernacles HM,Wooldridge ID,et al.Reversible ischemia around intracerebral hemorrhage:a single-photonemission computerized tomography [J].Neurosurgery,2002,96(4):736-741.
21. Rincon F, Mayer SA.Intracerebral hemorrhage:getting ready for effective treatments [J]. Curr Opin Neurol.2010; 23(1):59-64.
22. Kayana H and Kuroda K, et al.Development in neurosurgical approach to hypertensive intracerebral hemorrhage in Japan[J]. Raven Press, New York 1992:179-209.
23.Donnan G,Davis SM.Surgery for intracerebral hemorrhage:anvidence-poor zone [J].Stroke,2003,34:1569-1570.
24. Morgenstern LB,Frankowski RF,Shedden P,Pasteur W and.Grotta JC,Surgical treatment for intracerebral hemorrhage(STICH):a Single -center, randomized clinical trial [J].Neurology 1998,51:1359-1363.
25. Nakano T and Ohkuma H,Surgery versus conservative treatment for intracerebral hemorrhage:is there an end to the long controversy [J].Lancet 2005,365-361.
26. Muiz AJ,Abdullah J,Naing NN,Ghazaime G and Ariff AR, Spontaneous intracerebral hemorrhage in northeast Malaysian patients:a four-year study [J].Neuroepidemiology 2003,22:184-195.
27. Patrick Mitchell,Barbara A.Gregson,Raghu R.Vindlacheruvu,A.David Mendelo et al.,Surgical options in ICH including decompressive craniectomy [J].Journal of the Neurological Sciences 2007,261:89-98.
28. Neeraj S,Naval,Paul Nyquist and Ricardo Carhuapoma [J].ICH aspiration and thrombolysis,Neurological Sciences 2007,261:80-83.
29. Huang CF, Tsai ZP, Li CS,etal. Surgical improvement of brain edema related to hypertensive intracerebral hemorrhage [J]. Zhonghua Yi Xue Za Zhi (Taipei). 2002 Jun; 65(6):241-6.
30. Fountas KN, Kapsalaki EZ, Machinis T, et al. Review of the literature regarding the relationship of rebleeding and external ventricular drainage in patients with subarachnoid hemorrhage of aneurysmal origin [J]. Neurosurg Rev 2006;29:14-18.
31. Teernstra OP,Evers SM,Lodder J,Leffers P,Franke CL and Blaauw G, Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator:a multicenter randomized controlled trail(SICHPA) [J]. Stroke 2003,34:968-974.
32. Lee JI,Namdo H,Kim JS,Hong SC,Shin HJ.and Park K,et al.Stereotactic aspiration of intracerebral hematoma:significance ofsurgical timing and hematoma volume reduction [J].Clin Neurosci2003,10:439-443.
33. Marquardt G,Wolff R and Seifert V, Multiple target aspiration technique for subacute stereotactic aspiration of hematomas within the basal ganglia [J].Surg Neurol 2003,60:8-13.
34. Stein RW, Kase CS, Hier DB,et al. Caudate hemorrhage [J]. Neurology. 1984;34(12):1549-54.
35. Helweg-Larsen S, Sommer W,,et al. Strange P,Prognosis for patients treated conservatively for spontaneous intracerebral hematomas[J]. Stroke.1984 Nov-Dec; 15(6):1045-8.
36. Jensen MB,St Louis EK.Management of acute cerebellar stroke [J].Arch Neurol,2005,62(4):537～544.
37. Miyashita K, Naritomi H.Clinicostatistical analysis of thalamic hemorrhage [J].Nippon Rinsho.2006,28; 64 Suppl 8:390-4.
38.李凤强,张兴春,于守波,赵英志.立体定向置管引流术治疗重型脑干出血[J].吉林医学,2002,23(5)：272-274
39.姜勇,张爱军,高军,李波.高血压性脑出血手术适应证多因素分析和数学模型的建立[J].中国临床神经外科杂志,2003,8(1)：30.
40. Naff NJ,Hanley DF,Keyl PM,et al.Intraventricular Thrombolysis Speeds Blood Clot Resolution: Results of a Pilot, Prospective, Randomized, Double-blind, Controlled Trial [J].Neurosurgery,2004,54(3),577-584.
41. Perez-Nunez A, Alday R, Rivas JJ, etal. Surgical treatment for spontaneous intracerebral haemorrhage. Part Ⅱ:infratentorial haematomas [J]. Neurocirugia (Astur).2008; 19(2):101-12.
42. Brott T,Broderick J,Kothari R,et al.Early hemorrhage growth in patients with intracerebral hemorrhage [J].Stroke,1997,28(1):1-5
43. Ziai WC, Torbey MT, Naff NJ, etal. Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage [J]. Cerebrovasc Dis.2009; 27(4):403-10.
44. Staykov D, Huttner HB, Lunkenheimer J, etal. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage [J]. Neurol Neurosurg Psychiatry.2010; 81(1):105-8.
45. Niizuma和Suzuki(58. Niizuma, Hiroshi M.D.; Shimizu, Yukihiko M.D.; Yonemitsu, Tsutomu M.D.; etal. Results of Stereotactic Aspiration in 175 Cases of Putaminal Hemorrhage [J]. Neurosurgery,1989,24:814.
46. Saladino A, White JB, Wijdicks EF, et al.Malplacement of ventricular catheters by neurosurgeons:a single institution experience [J].Neurocrit Care 2009; 10:248-52.
47. Wang J, Dore S. Inflammation after intracerebral hemorrhage[J]. Journal of Cerebral Blood Flow Metabol,2007,27:894-908.
48.李颖,陆莲芳,张逸强.脑卒中患者胰岛素抵抗的初步观察[J].中华神经医学杂志,2003,7：302-303.
49. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections:a critical review[J].Neurosurgery.2002;51:170-81.
50. Roitberg BZ, Khan N, Alp MS, et al:Bedside external ventricular drain placement for the treatment of acute hydrocephalus [J]. Br J Neurosurg 2001; 15:324-327.
51. Zabramski JM, Whiting D, Darouiche RO, et al.Efficacy of antimicrobial-impregnated external ventricular drain catheters: A prospective,randomized, controlled trial [J]. Neurosurg 2003; 98:725-730.
52. Lo CH, Spelman D, Bailey M, et al:External ventricular drain infections are independent of drain duration:An argument against elective revision [J]. Neurosurg 2007; 106:378-383.
53. Leung GK, Ng KB, Taw BB, et al:Extended subcutaneous tunnelling technique for external ventricular drainage [J].Br J Neurosurg 2007; 21:359-364.
54. Sciubba DM, Stuart RM, McGirt MJ, et al.Effect of antibiotic -impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus [J]. Neurosurg 2005; 103:131-136.
55. Fountas KN, Kapsalaki EZ, Machinis T, et al. Review of the literature regarding the relationship of rebleeding and external ventricular drainage in patients with subarachnoid hemorrhage of aneurysmal origin [J]. Neurosurg Rev 2006;29:14-18.
56. Korinek AM, Reina M, Boch AL, et al.Prevention of external ventricular drain～related ventriculitis [J].Acta Neurochir (Wien) 2005; 147:39-45.
57. Anderson CS,Huang YN,Wang JG,et al.Intensive blood pressure reduction in acute cerebral haemorrhage trial(INTERACT):a randomised pilot trial [J].Lancet Neural,2008,7(5):391-399.
1. Li SC, Schoenberg BS,Wang CC et al. Cerebrovascular disease in the People's Republic of China:epidemiologic and clinical features [J].Neurology 1985; 35: 1708-13.
2. Cheng XM, Li ZS, Yang QD et al. Geographic distribution of completed stroke, People's Republic of China [J].Chin J Neurosurg1989; 5:11-4.
3. Chinese Stroke Association, Ministry of Health, PRC:China Guidelines for Cerebrovascular Disease Preventionand Treatment [J].Beijing:People's Medical Publishing House,2007.
4. Jiang B,Wang WZ, Chen H et al. Incidence and trends of stroke and its subtypes in China. Results from three large cities [J].Stroke 2006;37:63-8.
5. MendelowAD, Gregson BA, FernandesHMet al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH):a randomised trial [J].Lancet 2005; 365:387-97.
6. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults:2007 update:a guideline from the American Heart Association/American Stroke Association Stroke Council,High Blood Pressure Research Council, and theQuality of Care and Outcomes in Research Interdisciplinary Working Group [J]. Stroke 2007; 38:2001-2023.
7. Mayer SA, Rincon F. Treatment of intracerebral haemorrhage [J]. Lancet Neurol 2005; 4:662-672.
8. Morgan T, Awad I, Keyl P, et al. Preliminary report of the Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR-IVH) clinical Trial [J]. Acta Neurochir Suppl 2008; 105:217-220.
9. Bekar A, Bilgin H, Korfali G, et al.Minimally invasive awake craniotomy using Steiner-Lindquist stereotactic laser guidance [J]. Minim Invasive Neurosurg.2009 Aug;52(4):176-9.
10. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage [J]. Crit Care Med 2001; 29:635-640.
11. Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care:evidence-based support for an intensivist-directed specialty ICU model of care [J]. J Neurosurg Anesthesiol 2001;13:83-92.
12. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage [J]. Neurology 1994;44: 1379-1384.
13. Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage:indications, timing, and outcome [J]. Neurology,1998; 51:447-451.
14. Mayer SA, Chong J. Critical care management of increased intracranial pressure [J]. J Intensive Care Med 2002; 17:55-67.
15. Kazui S, Minematsu K, Yamamoto H, et al. Predisposing factors to enlargement of spontaneous intracerebral hematoma [J]. Stroke 1997; 28:2370-2375.
16. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth:an exploratory analysis [J]. Stroke 2007; 38:1072-1075.
17. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage [J]. Stroke 1997; 28:1-5.
18. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 h) intracerebral hemorrhage [J]. Neurology,2001; 57:18-24.
19. Powers WJ, Adams RE, Yundt KD. Acute pharmacological hypotension after intracerebral hemorrhage does not change cerebral blood flow [J].Stroke 1999; 30: 242.
20. Qureshi Al, Wilson DA, Hanley DF, Traystman RJ. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage [J]. Crit Care Med 1999; 27:965-971.
21. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) trial [J]. International Stroke Conference; February 20-22,2008; New Orleans, LA.2008.
22. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT):a randomised pilot trial [J]. Lancet Neurol 2008; 7:391-399.
23. Kuwata N, Kuroda K, Funayama M, et al. Dysautoregulation in patients with hypertensive intracerebral hemorrhage [J]. A SPECT study. Neurosurg Rev 1995; 18:237-245.
24. Mayer SA, Lignelli A, Fink ME, et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage:a SPECT study [J]. Stroke 1998; 29:1791-1798.
25. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage [J].N Engl J Med 2001; 344:1450-1460.
26. Fujii Y, Takeuchi S, Sasaki O, et al. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage [J]. Stroke 1998; 29:1160-1166.
27. Fujii Y, Tanaka R, Takeuchi S, et al. Hematoma enlargement in spontaneous intracerebral hemorrhage [J]. J Neurosurg 1994; 80:51-57.
28. Kazui S, Naritomi H, Yamamoto H, et al. Enlargement of spontaneous intracerebral hemorrhage [J]. Incidence and time course. Stroke 1996;27: 1783-1787.
29. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage [J]. N Engl J Med 2005; 352:777-785.
30. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage [J]. N Engl J Med 2008; 358:2127-2137.
31. Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor Ⅶ? [J] Stroke 2009; 40:833-840.
32. Wintzen AR, de Jonge H, Loeliger EA, Bots GT. The risk of intracerebral hemorrhage during oral anticoagulant therapy:a population study [J]. Ann Neurol 1984;16:553-558.
33. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses [J]. Stroke 1995; 26:1471-1477.
34. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage [J]. Stroke 1992; 23:972-977.
35. Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal:the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy [J]. Thromb Haemost 1997; 77:477-480.
36. Yasaka M, Sakata T, Minematsu K, Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication [J]. Thromb Res 2002; 108:25-30.
37. Heit JA. Perioperative management of the chronically anticoagulated patient [J]. J Thromb Thrombolysis 2001; 12:81-87.
38. Sorensen B, Johansen P, Nielsen GL,et al. Reversal of the International Normalized Ratio with recombinant activated factor Ⅶ in central nervous system bleeding during warfarin thromboprophylaxis:clinical and biochemical aspects [J]. Blood Coagul Fibrinolysis 2003; 14:469-477.
39. Erhardtsen E, Nony P, Dechavanne M, et al. The effect of recombinant factor Ⅶa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0 [J]. Blood Coagul Fibrinolysis 1998;9:741-748.
40. Freeman WD, Brott TG, Barrett KM, et al. Recombinant factor Ⅶa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage [J]. Mayo Clin Proc 2004; 79:1495-1500.
41. Ananthasubramaniam K, Beattie JN, Rosman HS, et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? [J] Chest 2001; 119: 478-484.
42. Butler AC, Tait RC. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage:a 2-year follow-up [J]. Br J Haematol 1998;103:1064-1066.
43. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk [J]. Arch Neurol 2000; 57:1710-1713.
44. Wakefield TW, Stanley JC. Intraoperative heparin anticoagulation and its reversal [J]. Semin Vasc Surg 1996; 9:296-302.
45. Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia [J]. N Engl J Med 1983; 308:8-12.
46. Sansing LH, Messe SR, Cucchiara BL, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH [J]. Neurology 2009; 72:1397-1402.
47. Moussouttas M, Malhotra R, Fernandez L, et al. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage [J]. Neurocrit Care.2010;12(1):24-9.
48. Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr, et al. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage [J]. J Stroke Cerebrovasc Dis 2009; 18:221-228.
49. Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage [J]. Stroke 2009; 40:2398-2401.
50. Naval NS, Abdelhak TA, Zeballos P, et al. Prior statin use reduces mortality in intracerebral hemorrhage [J]. Neurocritical care 2008; 8:6-12.
51. Naval NS, Abdelhak TA, Urrunaga N, et al. An association of prior statin use with decreased perihematomal edema [J]. Neurocritical care 2008;8:13-18.
52. Leker RR, Khoury ST, Rafaeli G, et al. Prior use of statins improves outcome in patients with intracerebral hemorrhage:prospective data from the National Acute Stroke Israeli Surveys (NASIS) [J]. Stroke 2009; 40: 2581-2584.
53. Tapia-Perez H, Sanchez-Aguilar M, Torres-Corzo JG, et al. Use of statins for the treatment of spontaneous intracerebral hemorrhage:results of a pilot study [J]. Cen Eur Neurosurg 2009; 70:15-20.
54. Juvela S, Heiskanen O, Poranen A, et al. The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment [J]. J Neurosurg 1989; 70:755-758.
55. Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial intracerebral hemorrhage:a randomized feasibility study [J]. Stroke 1999; 30: 1833-1839.
56. Fernandes HM, Gregson B, Siddique S, Mendelow AD [J].Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 2000; 31:2511-2516.
57. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH):a randomised trial [J]. Lancet 2005; 365:387-397.
58. Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial [J]. Acta Neurochir Suppl 2006; 96:65-68.
59. Murthy JM, Chowdary GV, Murthy TV, et al. Decompressive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage [J]. Neurocritical care 2005; 2:258-262.
60. Wang WZ, Jiang B, Liu HM, et al. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage:results from a randomized clinical trial in China [J]. Int J Stroke 2009; 4:11-16.
61. Teernstra OP, Evers SM, Lodder J, et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator:a multicenter randomized controlled trial (SICHPA) [J]. Stroke 2003; 34:968-974.
62. Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score:a simple, reliable grading scale for intracerebral hemorrhage [J]. Stroke 2001; 32:891-897.
63. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase:effects on 30-Day survival [J]. Stroke 2000; 31:841-847.
64. Demaerschalk BM. Fibrinolytic therapy for intraventricular hemorrhage:is the answer becoming clear yet? [J]. Eur J Neurol.2008;15(4):320-322.
2. Magladery JW. The natural course of cerebrovascular hemorrhage [J].Clin Neurosurg.1963;9:106-13.
3. Donley,John James Wepfer.A renaissance student of apoplexy[J].Bull Johns Hopkins Hosp.1909,20:1-2.
4. Clarke E.Cerebrovascular system-historical aspects [M]. Radiology of the Skull and Brain,1974:875-889.
5. Fazio C.Clinical pathology of hypertensive intracerebral hemorrhage:Historical aspects[M].Raven Press,1983:105-113.
6. MacEwen W.An address on the surgery of the brain and spinal cord[M].BMJ 1888,20:302-309.
7. Cushing H.The blood-pressure reaction of acute cerebral compression,illustrated by cases of intracranial hemorrhage [J]. Am J Med Sci 1903,125:1017-1044.
8. Broderick J, Connolly S, Feldmann E,et al.Guidelines for the management of spontaneous intracerebral hemorrhage in adults:2007 update:a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group [J]. Stroke.2007; 38(6):2001-23.
9. Bagley CJ.Spontaneous cerebral hemorrhage:Disscussion of four types,with surgical considerations [J]. Arch Neurol Psychiatry,1932,27:1133-1174.
10. Robinson G.Encapsulates brain hemorrhage:A study of their frequency and pathology[J]. Arch Neurol Psychiatry,1932,27:1441-1444.
11. Craig W,Adson A.Spontaneous intracerebral hemorrhage:Etiology and surgical treatment with a report of nine cases[J]. Arch Neurol Psychiatry,1936,35:701-714.
12. Penfild W.The operative treatment of Spontaneous intracerebral hemorrhage[J]. Can Med Assoc J,1933,28:369-379.
13. LAZORTHES G. Surgery of cerebral hemorrhage; report on the results of 52 surgically treated cases[J]. J Neurosurg.1959;16(4):355-364.
14. McKissock W. Primary intracerebral hemorrhage:A controlled trial of surgical and conservative treatmene in 180 unselected cases[J]. Lancet 1961,2:221-226.
15. Sun TK, Chiu SC, Yeh SH, Chang KC. Assessing reliability and validity of the Chinese version of the stroke scale:scale development [J]. Int J Nurs Stud.2006 May; 43(4):457-63.
16. Towfighi A,Greenberg SM,Rosand J.Treatment and prevention of primary intracerebral hemorrhage [J]. Semin Neurol,2005,25 (4):445-452.
17. Herman M,Dvorak P,Houdek M.CT-guided stereotaxy:First 10-year experience [J].Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2003,147(2):221-226.
18. Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G.Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. [J].Stroke.1993 Jul;24(7):987-93.
19.戴秀珍.锥颅或钻颅血肿引流术治疗脑出血的适应症、手术时机及手术方式选择[J].临床神经病学杂志,2001,14(2)：112-114.
20. Siddique MS,Fernacles HM,Wooldridge ID,et al.Reversible ischemia around intracerebral hemorrhage:a single-photonemission computerized tomography [J].Neurosurgery,2002,96(4):736-741.
21. Rincon F, Mayer SA.Intracerebral hemorrhage:getting ready for effective treatments [J]. Curr Opin Neurol.2010; 23(1):59-64.
22. Kayana H and Kuroda K, et al.Development in neurosurgical approach to hypertensive intracerebral hemorrhage in Japan[J]. Raven Press, New York 1992:179-209.
23.Donnan G,Davis SM.Surgery for intracerebral hemorrhage:anvidence-poor zone [J].Stroke,2003,34:1569-1570.
24. Morgenstern LB,Frankowski RF,Shedden P,Pasteur W and.Grotta JC,Surgical treatment for intracerebral hemorrhage(STICH):a Single -center, randomized clinical trial [J].Neurology 1998,51:1359-1363.
25. Nakano T and Ohkuma H,Surgery versus conservative treatment for intracerebral hemorrhage:is there an end to the long controversy [J].Lancet 2005,365-361.
26. Muiz AJ,Abdullah J,Naing NN,Ghazaime G and Ariff AR, Spontaneous intracerebral hemorrhage in northeast Malaysian patients:a four-year study [J].Neuroepidemiology 2003,22:184-195.
27. Patrick Mitchell,Barbara A.Gregson,Raghu R.Vindlacheruvu,A.David Mendelo et al.,Surgical options in ICH including decompressive craniectomy [J].Journal of the Neurological Sciences 2007,261:89-98.
28. Neeraj S,Naval,Paul Nyquist and Ricardo Carhuapoma [J].ICH aspiration and thrombolysis,Neurological Sciences 2007,261:80-83.
29. Huang CF, Tsai ZP, Li CS,etal. Surgical improvement of brain edema related to hypertensive intracerebral hemorrhage [J]. Zhonghua Yi Xue Za Zhi (Taipei). 2002 Jun; 65(6):241-6.
30. Fountas KN, Kapsalaki EZ, Machinis T, et al. Review of the literature regarding the relationship of rebleeding and external ventricular drainage in patients with subarachnoid hemorrhage of aneurysmal origin [J]. Neurosurg Rev 2006;29:14-18.
31. Teernstra OP,Evers SM,Lodder J,Leffers P,Franke CL and Blaauw G, Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator:a multicenter randomized controlled trail(SICHPA) [J]. Stroke 2003,34:968-974.
32. Lee JI,Namdo H,Kim JS,Hong SC,Shin HJ.and Park K,et al.Stereotactic aspiration of intracerebral hematoma:significance ofsurgical timing and hematoma volume reduction [J].Clin Neurosci2003,10:439-443.
33. Marquardt G,Wolff R and Seifert V, Multiple target aspiration technique for subacute stereotactic aspiration of hematomas within the basal ganglia [J].Surg Neurol 2003,60:8-13.
34. Stein RW, Kase CS, Hier DB,et al. Caudate hemorrhage [J]. Neurology. 1984;34(12):1549-54.
35. Helweg-Larsen S, Sommer W,,et al. Strange P,Prognosis for patients treated conservatively for spontaneous intracerebral hematomas[J]. Stroke.1984 Nov-Dec; 15(6):1045-8.
36. Jensen MB,St Louis EK.Management of acute cerebellar stroke [J].Arch Neurol,2005,62(4):537～544.
37. Miyashita K, Naritomi H.Clinicostatistical analysis of thalamic hemorrhage [J].Nippon Rinsho.2006,28; 64 Suppl 8:390-4.
38.李凤强,张兴春,于守波,赵英志.立体定向置管引流术治疗重型脑干出血[J].吉林医学,2002,23(5)：272-274
39.姜勇,张爱军,高军,李波.高血压性脑出血手术适应证多因素分析和数学模型的建立[J].中国临床神经外科杂志,2003,8(1)：30.
40. Naff NJ,Hanley DF,Keyl PM,et al.Intraventricular Thrombolysis Speeds Blood Clot Resolution: Results of a Pilot, Prospective, Randomized, Double-blind, Controlled Trial [J].Neurosurgery,2004,54(3),577-584.
41. Perez-Nunez A, Alday R, Rivas JJ, etal. Surgical treatment for spontaneous intracerebral haemorrhage. Part Ⅱ:infratentorial haematomas [J]. Neurocirugia (Astur).2008; 19(2):101-12.
42. Brott T,Broderick J,Kothari R,et al.Early hemorrhage growth in patients with intracerebral hemorrhage [J].Stroke,1997,28(1):1-5
43. Ziai WC, Torbey MT, Naff NJ, etal. Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage [J]. Cerebrovasc Dis.2009; 27(4):403-10.
44. Staykov D, Huttner HB, Lunkenheimer J, etal. Single versus bilateral external ventricular drainage for intraventricular fibrinolysis in severe ventricular haemorrhage [J]. Neurol Neurosurg Psychiatry.2010; 81(1):105-8.
45. Niizuma和Suzuki(58. Niizuma, Hiroshi M.D.; Shimizu, Yukihiko M.D.; Yonemitsu, Tsutomu M.D.; etal. Results of Stereotactic Aspiration in 175 Cases of Putaminal Hemorrhage [J]. Neurosurgery,1989,24:814.
46. Saladino A, White JB, Wijdicks EF, et al.Malplacement of ventricular catheters by neurosurgeons:a single institution experience [J].Neurocrit Care 2009; 10:248-52.
47. Wang J, Dore S. Inflammation after intracerebral hemorrhage[J]. Journal of Cerebral Blood Flow Metabol,2007,27:894-908.
48.李颖,陆莲芳,张逸强.脑卒中患者胰岛素抵抗的初步观察[J].中华神经医学杂志,2003,7：302-303.
49. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections:a critical review[J].Neurosurgery.2002;51:170-81.
50. Roitberg BZ, Khan N, Alp MS, et al:Bedside external ventricular drain placement for the treatment of acute hydrocephalus [J]. Br J Neurosurg 2001; 15:324-327.
51. Zabramski JM, Whiting D, Darouiche RO, et al.Efficacy of antimicrobial-impregnated external ventricular drain catheters: A prospective,randomized, controlled trial [J]. Neurosurg 2003; 98:725-730.
52. Lo CH, Spelman D, Bailey M, et al:External ventricular drain infections are independent of drain duration:An argument against elective revision [J]. Neurosurg 2007; 106:378-383.
53. Leung GK, Ng KB, Taw BB, et al:Extended subcutaneous tunnelling technique for external ventricular drainage [J].Br J Neurosurg 2007; 21:359-364.
54. Sciubba DM, Stuart RM, McGirt MJ, et al.Effect of antibiotic -impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus [J]. Neurosurg 2005; 103:131-136.
55. Fountas KN, Kapsalaki EZ, Machinis T, et al. Review of the literature regarding the relationship of rebleeding and external ventricular drainage in patients with subarachnoid hemorrhage of aneurysmal origin [J]. Neurosurg Rev 2006;29:14-18.
56. Korinek AM, Reina M, Boch AL, et al.Prevention of external ventricular drain～related ventriculitis [J].Acta Neurochir (Wien) 2005; 147:39-45.
57. Anderson CS,Huang YN,Wang JG,et al.Intensive blood pressure reduction in acute cerebral haemorrhage trial(INTERACT):a randomised pilot trial [J].Lancet Neural,2008,7(5):391-399.
1. Li SC, Schoenberg BS,Wang CC et al. Cerebrovascular disease in the People's Republic of China:epidemiologic and clinical features [J].Neurology 1985; 35: 1708-13.
2. Cheng XM, Li ZS, Yang QD et al. Geographic distribution of completed stroke, People's Republic of China [J].Chin J Neurosurg1989; 5:11-4.
3. Chinese Stroke Association, Ministry of Health, PRC:China Guidelines for Cerebrovascular Disease Preventionand Treatment [J].Beijing:People's Medical Publishing House,2007.
4. Jiang B,Wang WZ, Chen H et al. Incidence and trends of stroke and its subtypes in China. Results from three large cities [J].Stroke 2006;37:63-8.
5. MendelowAD, Gregson BA, FernandesHMet al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH):a randomised trial [J].Lancet 2005; 365:387-97.
6. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults:2007 update:a guideline from the American Heart Association/American Stroke Association Stroke Council,High Blood Pressure Research Council, and theQuality of Care and Outcomes in Research Interdisciplinary Working Group [J]. Stroke 2007; 38:2001-2023.
7. Mayer SA, Rincon F. Treatment of intracerebral haemorrhage [J]. Lancet Neurol 2005; 4:662-672.
8. Morgan T, Awad I, Keyl P, et al. Preliminary report of the Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR-IVH) clinical Trial [J]. Acta Neurochir Suppl 2008; 105:217-220.
9. Bekar A, Bilgin H, Korfali G, et al.Minimally invasive awake craniotomy using Steiner-Lindquist stereotactic laser guidance [J]. Minim Invasive Neurosurg.2009 Aug;52(4):176-9.
10. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage [J]. Crit Care Med 2001; 29:635-640.
11. Mirski MA, Chang CW, Cowan R. Impact of a neuroscience intensive care unit on neurosurgical patient outcomes and cost of care:evidence-based support for an intensivist-directed specialty ICU model of care [J]. J Neurosurg Anesthesiol 2001;13:83-92.
12. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage [J]. Neurology 1994;44: 1379-1384.
13. Gujjar AR, Deibert E, Manno EM, et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage:indications, timing, and outcome [J]. Neurology,1998; 51:447-451.
14. Mayer SA, Chong J. Critical care management of increased intracranial pressure [J]. J Intensive Care Med 2002; 17:55-67.
15. Kazui S, Minematsu K, Yamamoto H, et al. Predisposing factors to enlargement of spontaneous intracerebral hematoma [J]. Stroke 1997; 28:2370-2375.
16. Broderick JP, Diringer MN, Hill MD, et al. Determinants of intracerebral hemorrhage growth:an exploratory analysis [J]. Stroke 2007; 38:1072-1075.
17. Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage [J]. Stroke 1997; 28:1-5.
18. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 h) intracerebral hemorrhage [J]. Neurology,2001; 57:18-24.
19. Powers WJ, Adams RE, Yundt KD. Acute pharmacological hypotension after intracerebral hemorrhage does not change cerebral blood flow [J].Stroke 1999; 30: 242.
20. Qureshi Al, Wilson DA, Hanley DF, Traystman RJ. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage [J]. Crit Care Med 1999; 27:965-971.
21. Qureshi AI. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) trial [J]. International Stroke Conference; February 20-22,2008; New Orleans, LA.2008.
22. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT):a randomised pilot trial [J]. Lancet Neurol 2008; 7:391-399.
23. Kuwata N, Kuroda K, Funayama M, et al. Dysautoregulation in patients with hypertensive intracerebral hemorrhage [J]. A SPECT study. Neurosurg Rev 1995; 18:237-245.
24. Mayer SA, Lignelli A, Fink ME, et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage:a SPECT study [J]. Stroke 1998; 29:1791-1798.
25. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage [J].N Engl J Med 2001; 344:1450-1460.
26. Fujii Y, Takeuchi S, Sasaki O, et al. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage [J]. Stroke 1998; 29:1160-1166.
27. Fujii Y, Tanaka R, Takeuchi S, et al. Hematoma enlargement in spontaneous intracerebral hemorrhage [J]. J Neurosurg 1994; 80:51-57.
28. Kazui S, Naritomi H, Yamamoto H, et al. Enlargement of spontaneous intracerebral hemorrhage [J]. Incidence and time course. Stroke 1996;27: 1783-1787.
29. Mayer SA, Brun NC, Begtrup K, et al. Recombinant activated factor VII for acute intracerebral hemorrhage [J]. N Engl J Med 2005; 352:777-785.
30. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage [J]. N Engl J Med 2008; 358:2127-2137.
31. Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor Ⅶ? [J] Stroke 2009; 40:833-840.
32. Wintzen AR, de Jonge H, Loeliger EA, Bots GT. The risk of intracerebral hemorrhage during oral anticoagulant therapy:a population study [J]. Ann Neurol 1984;16:553-558.
33. Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses [J]. Stroke 1995; 26:1471-1477.
34. Fredriksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracerebral hemorrhage [J]. Stroke 1992; 23:972-977.
35. Makris M, Greaves M, Phillips WS, et al. Emergency oral anticoagulant reversal:the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy [J]. Thromb Haemost 1997; 77:477-480.
36. Yasaka M, Sakata T, Minematsu K, Naritomi H. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication [J]. Thromb Res 2002; 108:25-30.
37. Heit JA. Perioperative management of the chronically anticoagulated patient [J]. J Thromb Thrombolysis 2001; 12:81-87.
38. Sorensen B, Johansen P, Nielsen GL,et al. Reversal of the International Normalized Ratio with recombinant activated factor Ⅶ in central nervous system bleeding during warfarin thromboprophylaxis:clinical and biochemical aspects [J]. Blood Coagul Fibrinolysis 2003; 14:469-477.
39. Erhardtsen E, Nony P, Dechavanne M, et al. The effect of recombinant factor Ⅶa (NovoSeven) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0 [J]. Blood Coagul Fibrinolysis 1998;9:741-748.
40. Freeman WD, Brott TG, Barrett KM, et al. Recombinant factor Ⅶa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage [J]. Mayo Clin Proc 2004; 79:1495-1500.
41. Ananthasubramaniam K, Beattie JN, Rosman HS, et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? [J] Chest 2001; 119: 478-484.
42. Butler AC, Tait RC. Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage:a 2-year follow-up [J]. Br J Haematol 1998;103:1064-1066.
43. Phan TG, Koh M, Wijdicks EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk [J]. Arch Neurol 2000; 57:1710-1713.
44. Wakefield TW, Stanley JC. Intraoperative heparin anticoagulation and its reversal [J]. Semin Vasc Surg 1996; 9:296-302.
45. Mannucci PM, Remuzzi G, Pusineri F, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia [J]. N Engl J Med 1983; 308:8-12.
46. Sansing LH, Messe SR, Cucchiara BL, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH [J]. Neurology 2009; 72:1397-1402.
47. Moussouttas M, Malhotra R, Fernandez L, et al. Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage [J]. Neurocrit Care.2010;12(1):24-9.
48. Creutzfeldt CJ, Weinstein JR, Longstreth WT Jr, et al. Prior antiplatelet therapy, platelet infusion therapy, and outcome after intracerebral hemorrhage [J]. J Stroke Cerebrovasc Dis 2009; 18:221-228.
49. Naidech AM, Jovanovic B, Liebling S, et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage [J]. Stroke 2009; 40:2398-2401.
50. Naval NS, Abdelhak TA, Zeballos P, et al. Prior statin use reduces mortality in intracerebral hemorrhage [J]. Neurocritical care 2008; 8:6-12.
51. Naval NS, Abdelhak TA, Urrunaga N, et al. An association of prior statin use with decreased perihematomal edema [J]. Neurocritical care 2008;8:13-18.
52. Leker RR, Khoury ST, Rafaeli G, et al. Prior use of statins improves outcome in patients with intracerebral hemorrhage:prospective data from the National Acute Stroke Israeli Surveys (NASIS) [J]. Stroke 2009; 40: 2581-2584.
53. Tapia-Perez H, Sanchez-Aguilar M, Torres-Corzo JG, et al. Use of statins for the treatment of spontaneous intracerebral hemorrhage:results of a pilot study [J]. Cen Eur Neurosurg 2009; 70:15-20.
54. Juvela S, Heiskanen O, Poranen A, et al. The treatment of spontaneous intracerebral hemorrhage. A prospective randomized trial of surgical and conservative treatment [J]. J Neurosurg 1989; 70:755-758.
55. Zuccarello M, Brott T, Derex L, et al. Early surgical treatment for supratentorial intracerebral hemorrhage:a randomized feasibility study [J]. Stroke 1999; 30: 1833-1839.
56. Fernandes HM, Gregson B, Siddique S, Mendelow AD [J].Surgery in intracerebral hemorrhage. The uncertainty continues. Stroke 2000; 31:2511-2516.
57. Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH):a randomised trial [J]. Lancet 2005; 365:387-397.
58. Bhattathiri PS, Gregson B, Prasad KS, Mendelow AD. Intraventricular hemorrhage and hydrocephalus after spontaneous intracerebral hemorrhage: results from the STICH trial [J]. Acta Neurochir Suppl 2006; 96:65-68.
59. Murthy JM, Chowdary GV, Murthy TV, et al. Decompressive craniectomy with clot evacuation in large hemispheric hypertensive intracerebral hemorrhage [J]. Neurocritical care 2005; 2:258-262.
60. Wang WZ, Jiang B, Liu HM, et al. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage:results from a randomized clinical trial in China [J]. Int J Stroke 2009; 4:11-16.
61. Teernstra OP, Evers SM, Lodder J, et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator:a multicenter randomized controlled trial (SICHPA) [J]. Stroke 2003; 34:968-974.
62. Hemphill JC 3rd, Bonovich DC, Besmertis L, et al. The ICH score:a simple, reliable grading scale for intracerebral hemorrhage [J]. Stroke 2001; 32:891-897.
63. Naff NJ, Carhuapoma JR, Williams MA, et al. Treatment of intraventricular hemorrhage with urokinase:effects on 30-Day survival [J]. Stroke 2000; 31:841-847.
64. Demaerschalk BM. Fibrinolytic therapy for intraventricular hemorrhage:is the answer becoming clear yet? [J]. Eur J Neurol.2008;15(4):320-322.